Premium
BioAtla Inc (BCAB)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071,... BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0506 | -8.16129032258 | 0.62 | 0.6835 | 0.5576 | 2143699 | 0.6269804 | CS |
| 4 | -1.0406 | -64.6335403727 | 1.61 | 1.62 | 0.5576 | 1619839 | 0.75445122 | CS |
| 12 | -1.4206 | -71.3869346734 | 1.99 | 2.525 | 0.5576 | 1131404 | 1.35516824 | CS |
| 26 | -0.7506 | -56.8636363636 | 1.32 | 2.525 | 0.5576 | 1152487 | 1.62744508 | CS |
| 52 | -1.8106 | -76.0756302521 | 2.38 | 4.02 | 0.5576 | 888773 | 1.92146868 | CS |
| 156 | -15.4106 | -96.436795995 | 15.98 | 16.49 | 0.5576 | 708475 | 3.7698767 | CS |
| 260 | -29.9806 | -98.1361702128 | 30.55 | 76.63 | 0.5576 | 587254 | 7.77722928 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
